appengine.ai

Artificial Intelligence | Machine Learning Scailyte | Precision Medicine Through Single-Cell Science


Enterprise, Biotechnology, Healthcare, Managed Healthcare, Health Diagnostics, Big Data, Pharmaceuticals Basel, Basel-Stadt, Switzerland

Scailyte

Artificial Intelligence | Machine Learning


Scailyte | Precision Medicine Through Single-Cell Science

Scailyte

Biotechnology, Healthcare, Managed Healthcare, Health Diagnostics, Big Data, Pharmaceuticals


Basel, Basel-Stadt, Switzerland

Scailyte develops artificial intelligence technology for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases by uncovering human's hidden "single-cell"? secrets. Our AI-based software ScaiVision offers best-in-class performance for supervised pattern recognition analysis of single-cell data. The performance and clinically-relevant application of the deep learning algorithm have been demonstrated in a scientific publication by our co-founder Prof. Claassen (ETH Zurich). ScaiVision will allow our customers to reduce data analysis time and costs, while increasing groundbreaking insights.

Moreover, we are also providing biomarker discovery services leveraging our expertise in single-cell technologies and our AI-based data analytics solutions. We support pharmaceutical companies during the drug discovery & development process by introducing and implementing single-cell approaches for the discovery of novel disease mechanisms, as well as the discovery of biomarkers for drug efficacy, toxicity, and patient stratification.

 

B2B

1 to 25

Series A

$6,889,835

Scaling Up

2017

 
 

Pharmaceuticals
Managed Health Care
Healthcare
Biotechnology

N/A

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning


Diagnostic Developments

Diagnostic Developments

Biomedical Insights

Biomedical Insights

Data Acquistion

Data Acquistion

Precision Diagnostic Portfolio

Precision Diagnostic Portfolio


Image

Image

Time Series

Time Series

 

   Software


N/A


Sensitive Algorithms

Sensitive Algorithms

Machine Learning

Machine Learning

 
 
Peter Nestorov


Peter Nestorov
Founder & CEO

Dennis Göhlsdorf


Dennis Göhlsdorf
CTO